Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (5400)	2/10/1998 9:44:00 PM
From: JFD	Read Replies (2) \| Respond to of 23519

According to Zacks, vvus is selling at less than 4x next years earnings. If this number is close to being right, why in the world is the stock at these levels? JFD

To: Mkilloran who wrote (5400)	2/10/1998 9:59:00 PM
From: DAVID	Read Replies (1) \| Respond to of 23519

Earnings summary from Stock Smart: Period** Year AgoMeanHigh*LowRpt Date Mar 98 Q10.27a***-0.040.04*-0.09Apr 8 Jun Q2****0.28a**0.130.16**0.09Jul 8 FY98****1.03***0.801.050.46*------ FY99***------***3.495.511.46***------ Quite a spread for FY99. FY98 seems a little low. FY98 $$$, what about Germany, Italy, France, Spain approval money ($0.20), UK new plant approval and product sales, Sweden approval and product sales, FDA approval of new plant and increased domestic sales, reduced cost of manufacturing from the new plant and the increased production capacity, etc ? Is there a projected estimated from anyone on the above without factoring in the cost of advertising? Is there anyone willing to take a best guess for the projected $cost$ of all the marketing and advertising occurring for FY98 from Vivus, Inc. ?